HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson's disease.

Abstract
Although neuroinflammation is known to play an important role in the pathogeneses of neurodegenerative diseases, few studies have been conducted on the association between Parkinson's disease (PD) and high-sensitivity C-reactive protein (hs-CRP), which is the most studied biomarker of systemic inflammation. Therefore, we conducted this study to determine the clinical correlates of hs-CRP levels in early PD patients by comparing findings with those of normal controls. Sixty-three drug-naïve patients with early PD and 117 healthy subjects were recruited, and hs-CRP level differences were investigated in these two groups. It was found that hs-CRP levels in the early PD group were higher than those of healthy controls. Furthermore, when compared with normal controls, the odds ratio for PD based on hs-CRP level cut-off of 0.5 was 2.094 (95% CI = 1.017-4.311, P = 0.045). In this study, our findings support the hypothesis that neuroinflammatory reactions play an important role in the pathogenesis of PD.
AuthorsIn-Uk Song, Sung-Woo Chung, Joong-Seok Kim, Kwang-Soo Lee
JournalNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Neurol Sci) Vol. 32 Issue 1 Pg. 31-4 (Feb 2011) ISSN: 1590-3478 [Electronic] Italy
PMID20532580 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • C-Reactive Protein
Topics
  • Aged
  • Biomarkers (metabolism)
  • C-Reactive Protein (metabolism)
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Odds Ratio
  • Parkinson Disease (metabolism)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: